BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 162254)

  • 1. Phosphorus-31 magnetic resonance studies on blood in Huntington's disease.
    Pettegrew JW; Glonek T; Stewart RM
    Trans Am Neurol Assoc; 1979; 104():233-5. PubMed ID: 162254
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane studies in Huntington's disease: steady-state fluorescence studies of intact erythrocytes.
    Pettegrew JW; Nichols JS; Stewart RM
    Ann Neurol; 1980 Oct; 8(4):381-6. PubMed ID: 6449174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte membrane alterations in Huntington disease: effects of gamma-aminobutyric acid.
    Butterfield DA; Braden ML; Markesbery WR
    J Supramol Struct; 1978; 9(1):125-30. PubMed ID: 215837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a membrane surface defect in erythrocytes in Huntington's disease.
    Butterfield DA; Doorley PF; Markesbery WR
    Life Sci; 1980 Aug; 27(7):609-15. PubMed ID: 6252406
    [No Abstract]   [Full Text] [Related]  

  • 5. Spin labeling studies of membrane proteins in erythrocyte ghosts from patients with Huntington's disease.
    Butterfield DA; Markesbery WR
    Neurosci Lett; 1983 Feb; 35(2):221-6. PubMed ID: 6304580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological diseases: Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy.
    Butterfield DA; Markesbery WR
    Trans Am Neurol Assoc; 1979; 104():57-60. PubMed ID: 162256
    [No Abstract]   [Full Text] [Related]  

  • 7. Time-dependence of, and effects of inhibition and cellular aging on, chloride efflux across erythrocyte membranes in Huntington's disease.
    Butterfield DA; Markesbery WR
    J Neurol Sci; 1982; 57(1):29-39. PubMed ID: 6296324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of Cl- transport in erythrocytes from patients with Huntington's disease.
    BiaƂas WA
    Gen Physiol Biophys; 1984 Oct; 3(5):403-11. PubMed ID: 6239808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease.
    Butterfield DA; Oeswein JQ; Markesbery WR
    Nature; 1977 Jun; 267(5610):453-5. PubMed ID: 195214
    [No Abstract]   [Full Text] [Related]  

  • 10. A genetic study of red cell osmotic fragility in Huntington's disease.
    McCormack MK; Lazzarini A; Toke D; Lepore F
    Am J Med Genet; 1984 May; 18(1):5-11. PubMed ID: 6234801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sodium plus potassium adenosine triphosphatase activity in erythrocyte membranes in Huntington's disease.
    Butterfield DA; Oeswein JQ; Prunty ME; Hisle KC; Markesbery WR
    Ann Neurol; 1978 Jul; 4(1):60-2. PubMed ID: 211930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of human erythrocyte membranes in normal people and in Huntington's chorea patients].
    Zakharov SF; Shandala AM; Shcheglova MV; Gromov PS; Insarova NG; Sychova VA; Markova ED; Shishkin SS; Ivanova-Smolenskaia IA
    Vopr Med Khim; 1990; 36(6):71-3. PubMed ID: 1963719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of N-acetylaspartate in Huntington's disease: preliminary results.
    Ruggieri M; Serpino C; Ceci E; Sciruicchio V; Franco G; Pica C; Trojano M; Livrea P; de Tommaso M
    Mov Disord; 2012 Feb; 27(2):329-30. PubMed ID: 22038921
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical studies in Huntington's chorea. 4. The fatty acid composition of plasma and erythrocyte lipids.
    Borri P; Hooghwinkel GJ; Bruyn G
    Psychiatr Neurol Neurochir; 1966; 69(2):143-8. PubMed ID: 4225278
    [No Abstract]   [Full Text] [Related]  

  • 15. Huntington's disease: membrane abnormalities and protein glycosylation.
    Tourian A; Hung WY
    Prog Clin Biol Res; 1980; 39():195-204. PubMed ID: 6447295
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipids of the erythrocyte membrane in Huntington's disease].
    Hooghwinkel GJ; Borri P; Bruyn GW
    Sist Nerv; 1965; 17(2):53-9. PubMed ID: 4221056
    [No Abstract]   [Full Text] [Related]  

  • 17. Huntington's disease: A transcriptional report card from the peripheral blood: can it measure disease progression in Huntington's disease?
    Tabchy A; Housman D
    Eur J Hum Genet; 2006 Jun; 14(6):649-50. PubMed ID: 16538227
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythrocyte phosphate content in Huntington's disease.
    Sarpel G; Barr AN; Lubansky HJ; Omachi A
    Neurosci Lett; 1982 Jul; 31(1):91-6. PubMed ID: 6214732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron spin resonance, hematological, and deformability studies of erythrocytes from patients with Huntington's disease.
    Butterfield DA; Purdy MJ; Markesbery WR
    Biochim Biophys Acta; 1979 Mar; 551(2):452-8. PubMed ID: 217434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on erythrocyte membranes of patients with Huntington's disease.
    Dubbelman TM; de Bruijne AW; Van Steveninck J; Bruyn GW
    J Neurol Neurosurg Psychiatry; 1981 Jul; 44(7):570-3. PubMed ID: 6270282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.